- Conditions
- Breast Cancer
- Interventions
- Not listed
- Lead sponsor
- Agendia
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 481 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 17
- States / cities
- Palm Springs, California • Miami, Florida • Tampa, Florida + 13 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Breast Cancer
- Interventions
- Tamoxifen Citrate, Letrozole, Exemestane, Blueprint, Mammaprint
- Drug · Diagnostic Test
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Breast Cancer
- Interventions
- MammaPrint, BluePrint, and Full-Genome Testing
- Diagnostic Test
- Lead sponsor
- Agendia
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 30,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2037
- U.S. locations
- 130
- States / cities
- Birmingham, Alabama • Anchorage, Alaska • Phoenix, Arizona + 107 more
- Conditions
- Breast Cancer
- Interventions
- TAC chemotherapy, TC chemotherapy, Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy, TCH chemotherapy, T + trastuzumab followed by CEF + trastuzumab, Dose dense AC followed by T + trastuzumab, Dose dense AC followed by T + trastuzumab + pertuzumab, PTH followed by dose dense AC of FEC
- Drug
- Lead sponsor
- Agendia
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 226 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2017
- U.S. locations
- 9
- States / cities
- Mobile, Alabama • Clearwater, Florida • Miami, Florida + 6 more
- Conditions
- Invasive Mammary Carcinoma, Metastatic Breast Cancer
- Interventions
- Capecitabine, Endocrine-therapy, MammoPrint ® and BluePrint assays
- Drug · Other
- Lead sponsor
- Sonya Reid
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2037
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Nashville, Tennessee • Dallas, Texas
- Conditions
- Chinese
- Interventions
- Not listed
- Lead sponsor
- Agendia
- Industry
- Eligibility
- 18 Years to 70 Years · Female only
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Colon Cancer
- Interventions
- Not listed
- Lead sponsor
- Agendia
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2019
- U.S. locations
- 17
- States / cities
- Glendale, California • Laguna Hills, California • Long Beach, California + 13 more
- Conditions
- Breast Cancer
- Interventions
- MammaPrint 70-gene expression profile, BluePrint 80 gene expression profile
- Other
- Lead sponsor
- Agendia
- Industry
- Eligibility
- 18 Years to 90 Years · Female only
- Enrollment
- 1,142 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2021
- U.S. locations
- 76
- States / cities
- Glendale, Arizona • Scottsdale, Arizona • Berkeley, California + 67 more
- Conditions
- Hormone Receptor Positive Malignant Neoplasm of Breast
- Interventions
- MammaPrint
- Device
- Lead sponsor
- Agendia
- Industry
- Eligibility
- 18 Years to 90 Years · Female only
- Enrollment
- 820 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 53
- States / cities
- Phoenix, Arizona • Burbank, California • Palm Springs, California + 47 more